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Over the past few decades, we have encountered life in 
surprising new forms and in unusual spaces. Scientists have 
been able to derive stem cells from the inner cell masses of 
early human embryos and to keep these cell lines dividing 
and growing; mammals have been produced not through 
the fusion of gametes but with the help of cloning tech-
nologies; and mice have been “humanized.” Some of these 
entities have themselves been transformed and made mo-
bile. Human embryonic stem cell lines derived from an em-
bryo, for instance, have been “coaxed” into forming more 
specific and dedicated cell types, or they have found their 
way as bio-repositories. The rising number of such entities 
or “bio-objects” – as the recently established research net-
work “Bio-objects and their boundaries: Governing matters 
at the intersection of society, politics, and science,” funded 
by the COST program, suggests naming them – bears wit-
ness to the growing ability of the life sciences to control 
life, to intervene in it, and sometimes also quite literally to 
“make” it. The salience of these bio-objects in public spaces 
– such as institutions entrusted with the ordering of our 
collective life – in newspaper headlines or internet fora for 
patient groups, testifies to the hopes that many individual 
and collective actors in post-industrial societies invest in 
the life sciences, which are entrusted not only with the task 
of producing knowledge but also with the task of making 
our collective life healthier, safer, and more productive.
However, debates and controversies on these innovative 
entities, as well as on the technologies and practices that 
help to make and to sustain them, suggest that the pro-
cess of bio-objectification should not be understood 
as a one-way street. Such debates include, on one 
hand, controversies on who or what is amenable to be 
“objectified” – and how, but also less vociferous debates in 
which scientists, policy-makers, and other groups of actors 
discuss how to order these entities, who to entrust with 
their oversight, and in light of what sort of principles. We 
discuss this latter aspect in this contribution, which is the 
third in a series of contributions on “bio-objects” and “bio-
objectification” processes (1,2).
We briefly report on the research objectives of a Work-
ing Group within this research network that focuses on 
the “governance of bio-objects.” This group explores and 
compares how various bio-objects have been governed, 
seeks  to  identify  commonalities  and  differences,  and 
seeks to learn how different modes of governing bio-ob-
ject shape and interfere with bio-objectification process-
es. Here, we identify some of the dimensions that help 
us make this comparison in practice. However, before we 
outline these dimensions, we briefly clarify what kind of 
social processes and institutions we refer to as “gover-
nance of bio-objects.”
THe governance of bIo-obJecTs
Over the past three decades, the concept of governance 
has experienced a rapid rise in use both within and out-
side of the social sciences. However, its precise meaning 
remains ambiguous, and contested.
Two broad approaches can be identified: Some scholars 
use governance as a counter-concept to government, to 
designate the emergence of new modes of ordering and 
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coordinating that operate beyond and/or by other means 
than traditional state authorities, for instance by delegat-
ing responsibilities to non-state actors such as companies 
or civil society organizations. Scholars in this tradition talk 
about “governance without government” or about shifts 
from “government to governance,” referring to an increase 
in network-based coordination of different societal activi-
ties. Other scholars use governance more generally to refer 
to various modes of steering or coordinating, independent-
ly of whether state-actors are involved or not. Distinctions 
are made between hierarchies, markets, and networks as 
the main types of coordination mechanisms; however, the 
suggestion is that such mechanisms exist next to another. 
We base our work on the latter, more encompassing ap-
proach. This means we apply the concept of governance 
to all kinds of steering and coordination mechanisms that 
are brought to bear on bio-objects. Using this more gener-
ic understanding of governance, we compare the various 
modes in which bio-objects are ordered 1) across “polities,” 
such as different countries or nation states; 2) across differ-
ent types of bio-objects, such as stem cells or genetically 
modified organisms; and 3) across time, for example, by 
exploring temporal developments of governance within a 
particular fields, or “learning effects” that spill from one field 
to another. Here we sketch some of the dimensions with 
which we make this comparison in practice.
LocaTIon of responsIbILITy or agency
The first dimension of comparing different modes of gov-
ernance relates to the question of who is entrusted with 
governing and overseeing particular bio-objects. Here, it is 
customary to distinguish between public and private do-
mains of activity and responsibility, although some gover-
nance literature is occupied with the various ways in which 
this distinction is crossed, blurred, or dissolved in more net-
work-like  topographies  of  responsibility  and  distributed 
agency. Hence, in practical terms, this dimension can be 
considered as a continuum ranging from domains where 
public bodies are entirely responsible and operate in a 
conventional, hierarchical fashion through hard law, moni-
toring, and sanctioning (eg, traditional risk management), 
to domains that are left entirely to the private sector – such 
as the self-governance of science through its own bodies 
of oversight or through entrusting individual citizens or 
consumers with making their own informed decisions. In 
general, the location of governance and the allocation of 
rights and responsibilities tend to follow fairly established 
patterns.  However,  bio-objects  tend  to  blur  boundaries 
between such pre-established locations, for instance, by 
“sitting-in-between” traditions of scientific self-governance 
and interventions by state-authorities.
DrIvers of governance
The  second  dimension  in  the  comparison  of  different 
modes of governance that requires clarification is wheth-
er bio-objects trigger calls for revising existing regulations, 
institutional frameworks, or established boundaries. Such 
calls are often made. This does not imply that pre-estab-
lished frameworks are always modified or eliminated alto-
gether. However, pre-existing modes of governance tend 
to be modified and adapted. One way to compare these 
adaptations is to explore who the actors or “drivers” are 
that foresee the need for regulation, and how that need 
is framed in terms of responsibilities, rights, and duties. 
Drivers may include the perceived need to protect public 
goods, such as the physical safety of human beings and 
the environment, the moral and ethical dignity of human 
beings and animals, or the safeguarding of privacy. The 
drivers of regulation might just as well emerge from civil 
society organizations concerned with “human dignity” in 
light of developments in reproductive technologies, but 
they may also result from the needs of commercial ac-
tors to have legal clarification before making investment 
decisions.
purpose of governance
The third, related, dimension for a comparison between 
different modes of governance relates to the “purpose” of 
governance. Do actors argue that there is a need to revise 
regulatory frameworks in order to confine a bio-object to 
particular space or to impede the “objectification” of par-
ticular forms of life? Or is the need for a revision of regula-
tory mechanisms framed in terms of ensuring the facilita-
tion of bio-objectification processes or enabling smoother 
transitions from a bio-object as a promissory research ob-
ject in the laboratory to an approved therapy in the clin-
ic? There are instances in which actors call for regulatory 
barriers that contain – or disallow – particularly innovative 
creatures from coming into being. Often such barriers are 
drawn even before such innovative creatures exist. Bans on 
the reproductive cloning of human beings are an example 
of such a restriction or a permanent ban. In practice, how-
ever, these two dimensions often go hand in hand. Ge-
netically modified organisms regulation can serve as an 
example: the regulatory frameworks put in place by the 
European Commission are meant not just to facilitate 
the development and implementation of the tech-BIO-OBJECTS 82 Croat Med J. 2012;53:80-2
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nology, but also to protect human health and the environ-
ment from undesirable side effects (and, it can be argued, 
to protect the political system against public opposition to 
the technology). The key question in this dimension per-
tains to how different purposes of governance are config-
ured in relation to each other – and possibly made the ob-
ject of social controversy about the goals of governance.
TeMporaLITy of governance
A fourth dimension in our comparison of different modes 
of governance relates to the temporality of governance. 
This refers to whether governance is prospective or reac-
tive in relation to bio-objectification. Does governance aim 
to steer bio-objectification in particular directions (eg, set-
ting research agendas, designating social or medical prob-
lems to be solved) or is it mostly reacting to emerging bio-
objects, either to control undesirable effects or to search 
for potential applications of generic technologies?
In some domains and in some polities, it seems that there 
is a general shift under way from reactive to more prospec-
tive or proactive modes of governance. For instance:
• GMO regulation is increasingly about identifying poten-
tial hazards to human health and the environment prior 
to deliberate releases of new GMOs. This raises the “cogni-
tive costs,” as regulators need not only to understand ob-
servable phenomena, but also to model potential conse-
quences.
• “Public engagement” activities are increasingly directed at 
“upstream” activities, ensuring public engagement with re-
search and innovation agendas, rather than simply react-
ing to “downstream” outcomes.
Key questions in this dimension are thus not only the ac-
tual temporal ordering of “innovations” vis-à-vis “regulation” 
(whether regulatory frameworks are constantly behind or 
whether they actively shape innovations), but also more 
fundamentally what the “temporal ambitions” of different 
regulatory tools and frameworks are.
exTensIon of THe MoDes of governance
While all processes of bio-objectification are local in some 
sense, some processes reach wider or are more extensively 
networked than others. This also pertains to the mecha-
nisms of governance. Hence, fifth, we need to ask at what 
level processes of governance are located and at what 
level they (attempt to) exert influence. This reaches from 
very local practices, pertaining to perhaps just one particu-
lar laboratory or biobank organizing its work in a particular 
manner, over national frames of legislation to international 
and global regimes of governance, such as international 
patent laws or international conventions like the Cartage-
na protocol on biodiversity. The key question to ask in this 
dimension of comparison pertains to the extension of par-
ticular modes of governance, and whether or not specific 
regimes of governance are adequate in light of the circula-
tion of particular bio-objects and the reach of bio-objecti-
fication processes. Here, it is instructive to follow particular 
bio-objects and to explore, when they become “upscaled,” 
for instance, to regulatory bodies of the European Union, 
and when bio-objects instead remain within a particular 
level of governance.
concLusIon
When taken together, the dimensions outlined above form 
a multi-dimensional matrix of issues to consider when an-
alyzing  and  comparing  different  modes  of  governance. 
They help to identify commonalities and differences across 
different countries, across bio-objects, and levels of gover-
nance. However, they also help to visualize temporal pat-
terns or trends, such as an increasing trend for anticipatory 
modes of governance. Indeed, it seems that governance is 
decreasingly a practice that comes after the “bio-object;” 
instead, governance seems to be increasingly part of bio-
objectification processes, seeking to enable, to “smooth,” 
and to shorten such processes. This suggests that the mak-
ing of new life forms and the ordering of these life forms, 
but also of the processes that help engender them, are pro-
cesses that are increasingly closer tied and intermingled.
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